We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+7.51%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.46B
AUM Growth
-$38.8M
Cap. Flow
-$22M
Cap. Flow %
-1.5%
Top 10 Hldgs %
61.18%
Holding
86
New
16
Increased
26
Reduced
28
Closed
12

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$44.8M
2
RGEN icon
Repligen
RGEN
+$29.2M
3
INSP icon
Inspire Medical Systems
INSP
+$21.3M
4
NVO
Novo Nordisk
NVO
+$11.2M
5
HCA icon
HCA Healthcare
HCA
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$61.4M
2
PFE icon
Pfizer
PFE
+$30.6M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$26.2M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$20.1M
5
THC icon
Tenet Healthcare
THC
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 88.85%
2 Miscellaneous 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
76
Corbus Pharmaceuticals
CRBP
$211M
– –
-88,934
Closed -$3.49M
CVAC
77
DELISTED
CureVac
CVAC
– –
-515,691
Closed -$1.56M
KRYS icon
78
Krystal Biotech
KRYS
$10.4B
– –
-18,557
Closed -$3.3M
PFE icon
79
Pfizer
PFE
$159B
– –
-1,102,042
Closed -$30.6M
THC icon
80
Tenet Healthcare
THC
$21.5B
– –
-175,631
Closed -$18.5M
TSHA icon
81
Taysha Gene Therapies
TSHA
$1.88B
– –
-2,325,591
Closed -$6.67M
WAT icon
82
Waters Corp
WAT
$40.7B
– –
-13,628
Closed -$4.69M
VINC
83
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
-3,979
Closed -$403K
MOR
84
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
-165,924
Closed -$3.01M
TARO
85
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-263,541
Closed -$11.2M
SWAV
86
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-80,555
Closed -$26.2M
1 2 3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Eversept Partners held 86 positions worth $1.46B, down 2.6% from $1.5B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Eversept Partners's Q2 2024 filing shows 16 new, 26 increased, 28 reduced and 12 closed positions. Its largest new stake was Insmed: 1,155,588 shares worth $77.4M. The largest sale was Natera, an estimated $61.4M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 89% a quarter earlier, followed by Miscellaneous.

  • Eversept Partners's largest Q2 2024 buy was Insmed: 1,155,588 shares worth $77.4M.
  • Eversept Partners added most to Repligen in Q2 2024, an estimated $29.2M increase.
  • Eversept Partners's biggest Q2 2024 reduction was Natera, cutting an estimated $61.4M.
  • Eversept Partners fully exited Pfizer in Q2 2024, selling an estimated $30.6M.
  • Eversept Partners's ten largest holdings make up 61% of its $1.46B portfolio in Q2 2024.
  • Eversept Partners opened 16 new positions and closed 12 in Q2 2024.
  • Eversept Partners's portfolio value fell 2.6% quarter-over-quarter to $1.46B.

Based on Eversept Partners's 13F filing for Q2 2024, filed 14 Aug 2024.